• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

More Thoracic Biopsies Performed by Radiologists

Article

Radiologists behind increase in percutaneous thoracic biopsies, resulting in fewer invasive biopsies.

Radiologists are increasingly responsible for thoracic diagnosis as they perform more thoracic biopsies than ever before, according to a study published in the Journal of the American College of Radiology. Researchers from Thomas Jefferson University Hospital and Jefferson Medical College, in Philadelphia, Penn., sought to examine the utilization rate of various types of thoracic biopsies within the Medicare population. Primary claims submitted percutaneous thoracic biopsy, bronchoscopic thoracic biopsy, and surgical thoracic biopsy between 1998 and 2010 were reviewed. There were 176,125 total thoracic biopsies in 1998 and a drop to 167,911 (-4.7 percent) in 2010. There was a decrease from 5.47 per 1,000 in 1998 to 4.76 per 1,000 (−13.0%) in 2010 for all thoracic biopsies. There was an increase in percutaneous biopsy of 3.6 percent, decrease in surgical biopsy by 29.0 percent, and decrease in bronchoscopic biopsy by 19.6 percent. “In 2010, radiologists performed 96.4 percent (58,679) of all percutaneous biopsies,” the authors wrote. “Radiologists' thoracic biopsy market share increased from 26.2 percent (46,084 of 176,125) in 1998 to 35.0 percent (58,700 of 167,911) in 2010 (+33.6%).” The researchers concluded that radiologists are responsible for the increasing role of thoracic diagnosis, which may be the result of changing trends to less invasive procedures, differing patterns of reimbursement, and increased  availability of percutaneous biopsy.

Recent Videos
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.